New Jersey-based Sabinsa’s sister company and ingredient manufacturing arm Sami Labs Ltd., the Bangalore-based Indian multinational health science company, has acquired KCP Biotech.
This acquisition will help Sami Labs gain another foothold in the growing biotech market and will aim to strengthen its product portfolio for world markets, an the new facility, spread across five acres in Genome Valley with ultra-modern technology and world-class quality stringency, will be integrated with Sami’s existing Hyderabad facility near by, according to Sabinsa. The acquisition also adds three natural colors to the Sabinsa product line, red, yellow and orange made from paprika, turmeric and annatto, respectively.
With the addition of this ultra-modern manufacturing facility, an ISO certified facility situated at SP Biotech Park Genome Valley and Sami’s second in Hyderabad, the company now has seven manufacturing units, including Kunigal, Nelamangala, Dobaspet and Utah. Sabinsa/Sami’s R&D locations include Bengaluru and New Jersey.
“The additional biotech capabilities this acquisition brings will help us move more quickly bringing to market products and capabilities our dynamic R&D staff are constantly developing” said Dr. Muhammed Majeed, founder and director, Sabinsa. “And adding natural colors to our product offerings complements our existing ingredient portfolio, which is having great success in the global supply chain.”
Sabinsa will be offering these natural colors to customers in Europe, Japan, Australia, China, UAE, South Africa, Vietnam, Malaysia and the USA.
For more information, visit www.sabinsa.com.